A recent survey conducted on behalf of the National Institute for Health Research Clinical Research Network shows that 89% of people would be willing to take part in a clinical trial if they were diagnosed with a medical condition or disease. This figure has very positive implications for the enterprise of global clinical research, as patient enrollment is one of the defining aspects of its success. So why is it that half of all investigative sites under-enroll for patients, and 11% of sites fail to enroll a single patient for a clinical trial?
It’s award season, and we’re proud to announce a few new wins including an Rx Club Award and three American Graphic Design Awards, all for Creative Excellence. Congrats to our marketing and creative teams!
There are many variables to consider when creating an advertising campaign for your clinical research study, but among the most important is the decision of which mediums to deploy. It can be staggering to think about all of the ways in which your potential patients might learn about your clinical research opportunity, and deciding how to make your campaign most visible can be challenging.
Following an inspiring few days at last week’s SYNERGY conference in Boston, hosted by ACRES, we’re in London at the Allan Lloyds 9th Annual Optimizing Clinical Research Summit this week to share ideas with colleagues and speak about mHealth and patient engagement.
October 1, 2015 marks an important milestone for anyone using or accepting cards in the United States. Known as the EMV liability shift (EMV is an acronym for Europay, MasterCard, Visa), it’s a deadline that’s fueling the replacement of magnetic stripe cards for more secure, globally accepted smart chip cards in the U.S. by shifting the liability for fraudulent transactions from financial institutions to the merchants that continue to accept them. So what does all this mean for global study patient reimbursement programs?
In today’s competitive clinical study landscape, ensuring that your study stands out has never been more important. Communicating the right information with your target audience, and understanding how they ingest this information, is a major factor in building a successful recruitment campaign. That is why it is crucial that your campaign is culturally adapted— to ensure that it resonates with audiences in all countries and cultures.
Despite the rising popularity of mobile health applications in clinical trials throughout the globe, their use in Latin America is still rare. However, these tools have enormous potential for use in clinical research, patient monitoring, compliance, patient support, diagnostics, and preventions. We’re going to look into the benefits of using mobile health applications and their increasing prominence and demand throughout the region.
BBK welcomes Laura Ardigó as our guest contributor on the blog today. Laura is an independent clinical research consultant with broad experience working in multinational pharmaceutical companies and is currently the President at Fundación UnICA (United for Clinical Research in Argentina). She will be sharing her insights into the patient recruitment landscape of Latin America, discussing industry trends, assumptions, and how technologies and innovations can most effectively be used to support clinical research while keeping the patient first.
In last week’s post I focused on how socio-techno advancements, a balanced patient outreach plan, and optimal outreach strategies work to enhance patient recruitment and engagement. While those three trends are painting a picture for how to optimize the clinical trial practices of the future, there are two more top trends that will help to round out any campaign.
We recently posted about the consumerization of health care that is truly driving change. Today I’d like to look at a few trends to keep an eye on that will prepare us for clinical trial success in the coming years.
Topics: clinical trials